Pfizer STN 50 mg (Sutent 50 mg)
Generic Name: sunitinib
Pill with imprint Pfizer STN 50 mg is Brown, Capsule-shape and has been identified as Sutent 50 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.
Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer STN 50 mg
Sutent
- Generic Name
- sunitinib
- Imprint
- Pfizer STN 50 mg
- Strength
- 50 mg
- Color
- Brown
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC)
- 00069-0980
- Inactive Ingredients
-
mannitol, croscarmellose sodium, povidone k25, magnesium stearate, titanium dioxide, ferric oxide red, ferric oxide yellow, ferrosoferric oxide, shellac, propylene glycol, sodium hydroxide, potassium hydroxide
Note: Inactive ingredients may vary.
More about Sutent (sunitinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 26 Reviews
- Drug class: multikinase inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
